Multicenter open-label randomized phase II study of...

Medical Oncology 2019 / 6 Vol. 36; Iss. 6

Multicenter open-label randomized phase II study of second-line panitumumab and irinotecan with or without fluoropyrimidines in patients with KRAS wild-type metastatic colorectal cancer (PACIFIC study)

Nagata, Naoki, Maeda, Hiromichi, Ishibashi, Keiichiro, Hirata, Keiji, Makiyama, Akitaka, Iwamoto, Shigeyoshi, Takemoto, Hiroyoshi, Imasato, Mitsunobu, Yoshida, Yoichiro, Munemoto, Yoshinori, Tanaka, C
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
36
Language:
english
Journal:
Medical Oncology
DOI:
10.1007/s12032-019-1254-4
Date:
June, 2019
File:
PDF, 1.24 MB
english, 2019
Conversion to is in progress
Conversion to is failed